An Open, Single-Dose, Single-Centre, Phase I Study to Assess the Metabolism, Excretion and Pharmacokinetics of [14C]AZD1981 in Healthy Male Volunteers.
Phase of Trial: Phase I
Latest Information Update: 24 Aug 2016
At a glance
- Drugs AZD 1981 (Primary)
- Indications Asthma; Chronic obstructive pulmonary disease
- Focus Pharmacokinetics
- Acronyms ADME
- Sponsors AstraZeneca
- 24 Aug 2016 Results published in the British Journal of Clinical Pharmacology
- 17 Nov 2010 Additional location (United Kingdom) identified as reported by ClinicalTrials.gov.
- 17 Nov 2010 Actual initiation date changed from Jan 2010 to Feb 2010 as reported by ClinicalTrials.gov.